comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacinas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. o uso desta vacina deve ser de acordo com as recomendações oficiais.
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacinas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
anagrelida bluefish 0.5 mg cápsula
bluefish pharmaceuticals ab - anagrelida - cápsula - 0.5 mg - anagrelida, cloridrato mono-hidratada 0.6063 mg - anagrelide - genérico - duração do tratamento: longa duração
anagrelida bluefish 0.5 mg cápsula
bluefish pharmaceuticals ab - anagrelida - cápsula - 0.5 mg - anagrelida, cloridrato mono-hidratada 0.6063 mg - anagrelide - genérico - duração do tratamento: longa duração
olmesartan medoxomilo + hidroclorotiazida mylan 40 mg + 12.5 mg comprimido revestido por película
mylan, lda. - olmesartan medoxomilo + hidroclorotiazida - comprimido revestido por película - 40 mg + 12.5 mg - hidroclorotiazida 12.5 mg ; olmesartan medoxomilo 40 mg - olmesartan medoxomil and diuretics - genérico - duração do tratamento: longa duração
sunitinib bluepharma 37.5 mg cápsula
bluepharma genéricos - comércio de medicamentos s.a. - sunitinib - cápsula - 37.5 mg - cloridrato de sunitinib 40.939 mg - sunitinib - genérico - duração do tratamento: longa duração
sunitinib bluepharma 50 mg cápsula
bluepharma genéricos - comércio de medicamentos s.a. - sunitinib - cápsula - 50 mg - cloridrato de sunitinib 54.585 mg - sunitinib - genérico - duração do tratamento: longa duração
sunitinib bluepharma 12.5 mg cápsula
bluepharma genéricos - comércio de medicamentos s.a. - sunitinib - cápsula - 12.5 mg - cloridrato de sunitinib 13.646 mg - sunitinib - genérico - duração do tratamento: longa duração
olmesartan medoxomilo + hidroclorotiazida mylan 20 mg + 25 mg comprimido revestido por película
mylan, lda. - olmesartan medoxomilo + hidroclorotiazida - comprimido revestido por película - 20 mg + 25 mg - olmesartan medoxomilo 20 mg ; hidroclorotiazida 25 mg - olmesartan medoxomil and diuretics - genérico - duração do tratamento: longa duração
olmesartan medoxomilo + hidroclorotiazida mylan 40 mg + 25 mg comprimido revestido por película
mylan, lda. - olmesartan medoxomilo + hidroclorotiazida - comprimido revestido por película - 40 mg + 25 mg - hidroclorotiazida 25 mg ; olmesartan medoxomilo 40 mg - olmesartan medoxomil and diuretics - genérico - duração do tratamento: longa duração